dacarbazine has been researched along with Atypical Ductal Hyperplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belin, L; Bollet, MA; Campana, F; Decaudin, D; Fourquet, A; Haberer, S; Kirova, YM; Le Scodan, R; Moisson, P; Pierga, JY; Reyal, F; Savignoni, A; Stevens, D | 1 |
1 other study(ies) available for dacarbazine and Atypical Ductal Hyperplasia
Article | Year |
---|---|
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Combined Modality Therapy; Confidence Intervals; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymph Node Excision; Mastectomy, Segmental; Mechlorethamine; Mediastinum; Middle Aged; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2012 |